TAK-341
TAK-341-2001
Phase 2 small_molecule completed
Quick answer
TAK-341 for Multiple System Atrophy is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Multiple System Atrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed